ORGANIZERS
- Kazakhstan Association of Urology and Andrology
- Central Asian Congress of Urologists
- Scientific Centre of Urology named after Academician B.U. Dzharbussynov
SUPPORTED BY
STADA is an international pharmaceutical company that has been dedicated to caring for people's health for over 125 years, building trusting relationships with partners and consumers. The key areas of STADA include products in the Consumer Healthcare (CHC) segment, generics, and specialized medications (including biosimilars).
STADA's products are available in 120 countries around the world, including Kazakhstan.
In 2022, the CIS region became an independent business unit and was renamed "Eurasia," reporting directly to the headquarters in Germany. The regional headquarters of "Eurasia" is located in Almaty.
"Grand Medical Group," Switzerland, is a manufacturer of highly effective next-generation plant-based medicinal products. The company was founded in 1927 in Barcelona, Spain. Since then, an exclusive product, Resolutivo Regium - TUTUKON, has been meticulously developed and subsequently produced.
GMG operates in all major countries in Europe and Asia and continues to grow by utilizing various business models in all target countries.
The company has 78 products, 132 different forms, and 84 registered trademarks. There are more than 520 product licenses in the countries of operation. Local structuring is present in 13 countries. The products are exported to 16 separate markets under licensing agreements. There are 16 patent applications for formulations and technologies.
LLP "Abdi Ibrahim Global Pharm" (AIGP) is a pharmaceutical company that was established in October 2012 through the integration of two major pharmaceutical companies, "Abdi Ibrahim" (Turkey) and the Lancaster Group of Companies (Kazakhstan).
"Abdi İbrahim" is a leader in the pharmaceutical market in Turkey, with a century of experience in this sector. LLP "SP Global Pharm," founded in 2000 and part of the Lancaster Group of Companies (Kazakhstan), is one of the largest companies in the pharmaceutical industry of Kazakhstan, with a full cycle of drug production. The plant produces high-quality tablet and capsule forms of medications.
STADA's products are available in 120 countries around the world, including Kazakhstan.
In 2022, the CIS region became an independent business unit and was renamed "Eurasia," reporting directly to the headquarters in Germany. The regional headquarters of "Eurasia" is located in Almaty.
"Grand Medical Group," Switzerland, is a manufacturer of highly effective next-generation plant-based medicinal products. The company was founded in 1927 in Barcelona, Spain. Since then, an exclusive product, Resolutivo Regium - TUTUKON, has been meticulously developed and subsequently produced.
GMG operates in all major countries in Europe and Asia and continues to grow by utilizing various business models in all target countries.
The company has 78 products, 132 different forms, and 84 registered trademarks. There are more than 520 product licenses in the countries of operation. Local structuring is present in 13 countries. The products are exported to 16 separate markets under licensing agreements. There are 16 patent applications for formulations and technologies.
LLP "Abdi Ibrahim Global Pharm" (AIGP) is a pharmaceutical company that was established in October 2012 through the integration of two major pharmaceutical companies, "Abdi Ibrahim" (Turkey) and the Lancaster Group of Companies (Kazakhstan).
"Abdi İbrahim" is a leader in the pharmaceutical market in Turkey, with a century of experience in this sector. LLP "SP Global Pharm," founded in 2000 and part of the Lancaster Group of Companies (Kazakhstan), is one of the largest companies in the pharmaceutical industry of Kazakhstan, with a full cycle of drug production. The plant produces high-quality tablet and capsule forms of medications.
The History of Alpen Pharma AG in Kazakhstan began in 2007 with the opening of a representative office in Almaty. Pursuing effort to be closer to the patients, a team of professionals “Alpen Pharma” works in all regions of Kazakhstan, improving the accessibility of the entire spectrum of the company’s products.
70% of a huge staff of the Company employees consists of medical representatives i.e. a team of professionals with medical education that actively cooperates with pediatricians, internists, allergists, dermatologists, gynecologists, ENT specialist, gastroenterologists, resuscitators, surgeons, urologists, family physicians etc., as well as with chemists and pharmacists in all regions of Kazakhstan. Today, Alpen Pharma AG Representative Office in Kazakhstan successfully solves the challenges it faces, keeps developing and opening up new prospectives. The Company’s products portfolio is replenished on a yearly basis and has a large number of drugs that meet the needs of a wide range of patients and doctors of various specialties. Alpen Pharma AG Representative Office in Kazakhstan pays a lot of attention to cooperating with medical and health-care institutions, medical practitioners, pharmacists and patients; actively supports the scientific and practical conferences and seminars to facilitate the exchange of experience, as well as educational programs to improve the skills of doctors. Our brands: Prostamed, Distreptase, Solidagoren
70% of a huge staff of the Company employees consists of medical representatives i.e. a team of professionals with medical education that actively cooperates with pediatricians, internists, allergists, dermatologists, gynecologists, ENT specialist, gastroenterologists, resuscitators, surgeons, urologists, family physicians etc., as well as with chemists and pharmacists in all regions of Kazakhstan. Today, Alpen Pharma AG Representative Office in Kazakhstan successfully solves the challenges it faces, keeps developing and opening up new prospectives. The Company’s products portfolio is replenished on a yearly basis and has a large number of drugs that meet the needs of a wide range of patients and doctors of various specialties. Alpen Pharma AG Representative Office in Kazakhstan pays a lot of attention to cooperating with medical and health-care institutions, medical practitioners, pharmacists and patients; actively supports the scientific and practical conferences and seminars to facilitate the exchange of experience, as well as educational programs to improve the skills of doctors. Our brands: Prostamed, Distreptase, Solidagoren
Астеллас — фармацевтическая компания, ведущая бизнес более чем в 70 странах. Наш подход — концентрироваться на конкретных терапевтических областях, с целью непрерывного создания новых препаратов для лечения заболеваний, не имеющих эффективных способов лечения. Мы фокусируемся на глубокое понимание биологических механизмов. Мы выходим за рамки подхода создания рецептурных препаратов (Rx) и создаём Rx+® решения для здравоохранения, основанные на объединении нашего опыта и знаний с передовыми технологиями наших партнеров в различных областях медицины. Благодаря этим усилиям Астеллас находится в авангарде здравоохранения, обращая инновации в ценность для пациентов.
Информация для специалистов здравоохранения.
ТОО «Астеллас Фарма»
г.Алматы, пр.Аль-Фараби, 15, ПФЦ «Нурлы Тау», здание 4В, офис 19-4В-10
Тел.\Факс: +7 (727)311 - 13–90, 311-13-89
MAT-KZ-NON-2023-00011-KZ_OCT-2023
Besins Healthcare is a pharmaceutical company focused on the development of innovative drugs to support men's and women's health.
For the past 30 years, Besins Healthcare has been a strong presence in the production of innovative drugs for the maintenance of pregnancy and the treatment of gynecological diseases, and is also a recognized expert in the field of testosterone replacement therapy. Currently, the company's headquarters is located in Monaco, from where the operational management of regional offices and interaction with partner companies in more than 90 countries is carried out.
The international pharmaceutical company SPEY was founded in 2002, it has been represented in the pharmaceutical market of Kazakhstan since 2016.
SPEY KAZAKHSTAN has become one of the most dynamically developing global pharmaceutical companies during its activity!
SPEY’s branches are present in more than 20 countries: Russia, Armenia, Azerbaijan, Georgia, Kazakhstan, Tajikistan, Uzbekistan, Turkmenistan, Kyrgyzstan, India, Nepal, Mongolia, Philippines, Vietnam, Cambodia, Myanmar and the markets of Africa and Latin America!
All SPEY products are produced in factories equipped with advanced technology and approved by the world quality standards of the World Health Organization and Good Manufacturing Practice!
SPEY KAZAKHSTAN is engaged in development and marketing of high-quality and innovative pharmaceutical products for the needs of a wide range of therapeutic areas!
The company's mission is to improve the quality of people's lives, their health and well-being by providing effective and affordable medicines!
SPEY KAZAKHSTAN has become one of the most dynamically developing global pharmaceutical companies during its activity!
SPEY’s branches are present in more than 20 countries: Russia, Armenia, Azerbaijan, Georgia, Kazakhstan, Tajikistan, Uzbekistan, Turkmenistan, Kyrgyzstan, India, Nepal, Mongolia, Philippines, Vietnam, Cambodia, Myanmar and the markets of Africa and Latin America!
All SPEY products are produced in factories equipped with advanced technology and approved by the world quality standards of the World Health Organization and Good Manufacturing Practice!
SPEY KAZAKHSTAN is engaged in development and marketing of high-quality and innovative pharmaceutical products for the needs of a wide range of therapeutic areas!
The company's mission is to improve the quality of people's lives, their health and well-being by providing effective and affordable medicines!
BERLIN-CHEMIE is an innovative international drug manufacturer. Since 1992, BERLIN-CHEMIE has been part of the world-famous MENARINI Group, which has been the leader of the Italian pharmaceutical market for many decades. Within the MENARINI Group, BERLIN-CHEMIE is responsible for the pharmaceutical business in Germany, Eastern Europe and the CIS region.
"FERON" LLC is a Russian full-cycle pharmaceutical company: development, production, promotion of antiviral immunomodulatory drugs under the VIFERON® trademark (rectal suppositories, cream and gel).
The original formula of the VIFERON® product includes interferon alfa-2b and a complex of antioxidants - tocopherol acetate (vitamin E) and ascorbic acid (vitamin C), which enhance the therapeutic effect of interferon.
VIFERON® has been widely used in urology, dermatovenereology, gynecology, therapy, infectology, pediatrics, neonatology, obstetrics for more than 25 years.
The original formula of the VIFERON® product includes interferon alfa-2b and a complex of antioxidants - tocopherol acetate (vitamin E) and ascorbic acid (vitamin C), which enhance the therapeutic effect of interferon.
VIFERON® has been widely used in urology, dermatovenereology, gynecology, therapy, infectology, pediatrics, neonatology, obstetrics for more than 25 years.
Founded in 2002, Nobel AFF is the leading domestic manufacturer of pharmaceutical products in Kazakhstan with expansion of its activities in the CIS countries.
Certified by national and international bodies, Nobel AFF operates in accordance with international standards. The company has ISO 9001:2015 and ISO 17025 certificates, which confirm the quality of Nobel AFF. Nobel AFF is one of the first pharmaceutical manufacturers in the Republic of Kazakhstan, which received a GMP certificate.
The company produces 290 high-quality import-substituting drugs for the treatment of both widespread and orphan diseases, as well as malignant neoplasms. Nobel AFF contributes to the economy and the diversification of foreign trade of the Republic of Kazakhstan through exports. The company already exports 30% of its products to the markets of the CIS countries and aims to increase the share of exports through the Eurasian economic integration to 50%.
Our goal is to improve people's quality of life by producing high-quality medicines and providing accurate and useful information about the products we bring to market.
Certified by national and international bodies, Nobel AFF operates in accordance with international standards. The company has ISO 9001:2015 and ISO 17025 certificates, which confirm the quality of Nobel AFF. Nobel AFF is one of the first pharmaceutical manufacturers in the Republic of Kazakhstan, which received a GMP certificate.
The company produces 290 high-quality import-substituting drugs for the treatment of both widespread and orphan diseases, as well as malignant neoplasms. Nobel AFF contributes to the economy and the diversification of foreign trade of the Republic of Kazakhstan through exports. The company already exports 30% of its products to the markets of the CIS countries and aims to increase the share of exports through the Eurasian economic integration to 50%.
Our goal is to improve people's quality of life by producing high-quality medicines and providing accurate and useful information about the products we bring to market.
medac GmbH was founded in 1970 in Hamburg, Germany. Since its founding, the company has specialized in the diagnosis and treatment of oncological, urological and autoimmune diseases. medac mbH specializes in the production of sterile cytostatic drugs, oncological generics, drugs for fluorescent diagnostics and photodynamic therapy. By bringing together these interconnected and complementary areas «under one roof», medac GmbH is constantly breaking new ground in diagnostics and treatment for the benefit of patient health. Obvious success stories are the biggest incentive to continue research and development. For example, the medicine «Gliolan» was developed by medac GmbH for visualizing brain tumors during neurosurgical operations, which doubled the effectiveness of these neurosurgical interventions. Prefilled syringes and pens with methotrexate solutions (Metoject) for the treatment of rheumatoid arthritis maximize patient independence. Business relations at medac GmbH are based on the traditions of German Hansa business ethics, guaranteeing reliability and optimal customer service.
Modernization of the manufacturing of the immunobiological medicine «BCG medac» for intravesical therapy of patients with non-muscle-invasive bladder cancer will solve the problem of shortages and provide for all patients in need.
The company attaches great importance to the manufacturing of medicines, and is also focused on developing new and improving existing medicines. In the area of innovation, the company's activities are aimed not only at major common diseases, but also at the research and development of new drugs for the treatment of rare diseases.
Modernization of the manufacturing of the immunobiological medicine «BCG medac» for intravesical therapy of patients with non-muscle-invasive bladder cancer will solve the problem of shortages and provide for all patients in need.
The company attaches great importance to the manufacturing of medicines, and is also focused on developing new and improving existing medicines. In the area of innovation, the company's activities are aimed not only at major common diseases, but also at the research and development of new drugs for the treatment of rare diseases.
NPO Petrovax Pharm is the leader among Russian companies that develop and manufacture innovative medicinal products and vaccines. Company operates in compliance with GMP EU and ISO:9001 international standards. NPO Petrovax Pharm was founded in 1996. Since 2008, the company is the member of ARPM.
"Bionorica" increases the level of knowledge about the effectiveness and high safety profile of herbal medicines in modern medicine. Thanks to phytoniring, we unleash the power of nature and help people become healthy. Phytoneering is a combination of the gifts and opportunuties of nature (“phytos” - plant), as well as science and the production process (“engineering”), which plays an important role in the creation of herbal medicines.
The concept of phytoneering, which guides the company, allows us to unlock the healing potential of plants through scientific research and innovative technologies. Phytoneering allows Bionorica to develop and produce highly effective and safe medicines in accordance with modern requirements of science and progress. Bionorica adheres to high quality standards at all stages of production and strives for leadership in the growing segment of the phytomedicine market.
The concept of phytoneering, which guides the company, allows us to unlock the healing potential of plants through scientific research and innovative technologies. Phytoneering allows Bionorica to develop and produce highly effective and safe medicines in accordance with modern requirements of science and progress. Bionorica adheres to high quality standards at all stages of production and strives for leadership in the growing segment of the phytomedicine market.
KARL STORZ is a renowned manufacturer with a proven track record in all areas of endoscopy, as well as veterinary and technical endoscopy.
The company has maintained its tradition for over 75 years and is known today for its innovative and high-quality products, solutions for integrated operating rooms, visualization and documentation, and service.
It has been successfully operating in the Kazakhstan market since 2000, not only supplying equipment and instruments, but also introducing the latest medical technologies into clinical practice. Having all the necessary technological resources, the company takes an active part in the implementation of large medical projects.
The company has maintained its tradition for over 75 years and is known today for its innovative and high-quality products, solutions for integrated operating rooms, visualization and documentation, and service.
It has been successfully operating in the Kazakhstan market since 2000, not only supplying equipment and instruments, but also introducing the latest medical technologies into clinical practice. Having all the necessary technological resources, the company takes an active part in the implementation of large medical projects.
LLP "ABDI IBRAHIM GLOBAL PHARMA" (AIGP) is a pharmaceutical company that was established in October 2012 through the integration of two leading pharmaceutical companies, "ABDI IBRAHIM" (Turkey) and the Lancaster Group of companies (Kazakhstan).
"ABDI İBRAHIM" is a leader in the pharmaceutical market in Turkey with a century-long experience in the sector. TOO "SP Global Pharm," founded in 2000 and part of the Lancaster Group of companies (Kazakhstan), is one of the largest pharmaceutical companies in Kazakhstan, with a complete cycle of pharmaceutical production. The plant manufactures high-quality tablet and capsule forms of pharmaceuticals.
"AIGP" actively contributes to the improvement of the health of the citizens of the Republic of Kazakhstan and the enhancement of their quality of life. The company exports its products to Azerbaijan, Uzbekistan, Afghanistan, and Georgia. The company participates in state procurements conducted by the sole distributor TOO "SK Farmatsiya" for the purchase of medicinal products, as well as in tenders for the purchase of medicinal products within the framework of the guaranteed volume of free outpatient medical care. LLP "ABDI IBRAHIM GLOBAL PHARMA" produces over a hundred drugs that are widely used for the treatment and prevention of diabetes, tuberculosis, HIV, cardiological, psychoneurological, gastroenterological, urological, gynecological, endocrine, and other diseases.
"ABDI İBRAHIM" is a leader in the pharmaceutical market in Turkey with a century-long experience in the sector. TOO "SP Global Pharm," founded in 2000 and part of the Lancaster Group of companies (Kazakhstan), is one of the largest pharmaceutical companies in Kazakhstan, with a complete cycle of pharmaceutical production. The plant manufactures high-quality tablet and capsule forms of pharmaceuticals.
"AIGP" actively contributes to the improvement of the health of the citizens of the Republic of Kazakhstan and the enhancement of their quality of life. The company exports its products to Azerbaijan, Uzbekistan, Afghanistan, and Georgia. The company participates in state procurements conducted by the sole distributor TOO "SK Farmatsiya" for the purchase of medicinal products, as well as in tenders for the purchase of medicinal products within the framework of the guaranteed volume of free outpatient medical care. LLP "ABDI IBRAHIM GLOBAL PHARMA" produces over a hundred drugs that are widely used for the treatment and prevention of diabetes, tuberculosis, HIV, cardiological, psychoneurological, gastroenterological, urological, gynecological, endocrine, and other diseases.
Any success story begins with a good idea, and STADA is a clear proof of this.
STADA is an international pharmaceutical company that has been pursuing its mission for more than 125 years - to take care of people's health, building trusting relationships with partners and consumers.
The company name is the abbreviation St.d.A - Standardarzneimittel die Deutscher Apotheke, which translated from German means “Standard of German Pharmacy Drugs”.
STADA products are represented in 120 countries around the world. STADA entered the pharmaceutical market in Russia and the CIS countries in 2002. In 2022, STADA celebrates its twentieth anniversary since entering the Kazakh market.All these years, the company has been directing all its efforts to improve the health of the country's citizens, providing them with effective, safe and affordable medicines.
Today STADA is confidently among the TOP 5 largest companies in the pharmaceutical market of Kazakhstan. The company's product portfolio includes more than 80 types of medicines.
Commitment to ethical business standards, highly qualified employees, loyalty to quality traditions - all this ensures STADA's leadership in the production of generics in the world and sets guidelines for successful development in Kazakhstan.
STADA is an international pharmaceutical company that has been pursuing its mission for more than 125 years - to take care of people's health, building trusting relationships with partners and consumers.
The company name is the abbreviation St.d.A - Standardarzneimittel die Deutscher Apotheke, which translated from German means “Standard of German Pharmacy Drugs”.
STADA products are represented in 120 countries around the world. STADA entered the pharmaceutical market in Russia and the CIS countries in 2002. In 2022, STADA celebrates its twentieth anniversary since entering the Kazakh market.All these years, the company has been directing all its efforts to improve the health of the country's citizens, providing them with effective, safe and affordable medicines.
Today STADA is confidently among the TOP 5 largest companies in the pharmaceutical market of Kazakhstan. The company's product portfolio includes more than 80 types of medicines.
Commitment to ethical business standards, highly qualified employees, loyalty to quality traditions - all this ensures STADA's leadership in the production of generics in the world and sets guidelines for successful development in Kazakhstan.
